Toxicological Assessment of LN20188, a Botanical Combination of Withania somnifera Root and Abelmoschus esculentus Fruit Extracts.

LN20188 is a botanical combination composed of extracts derived from Withania somnifera (L.) Dunal root and Abelmoschus esculentus (L.) Moench fruit. Our earlier investigations revealed the benefits of LN20188 in promoting gut motility and reducing constipation. The current investigation presents th...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2026; pp. 1 - 18
Autores principales: Madireddy, Ravikumar, Dodda, Sundararaju, Chinta, Gopichand, Alluri, KrishnaRaju Venkata, Himangshu, Himangshu
Formato: pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell 3/31/2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=192658994&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 192658994
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 3/31/2026
      vid: 2026
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        192658994
        192658994
        192658994
        10.1155/bmri/6355273
        192658994
      ppf: 1
      ppct: 17
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Toxicological Assessment of LN20188, a Botanical Combination of Withania somnifera Root and Abelmoschus esculentus Fruit Extracts.
      aug:
        au:
          Madireddy, Ravikumar
          Dodda, Sundararaju
          Chinta, Gopichand
          Alluri, KrishnaRaju Venkata
          Himangshu, Himangshu
        affil: Department of Toxicology,, Laila Nutra Private Limited,, R&D Centre,, Vijayawada, Andhra Pradesh,, India
      sug:
        subj:
          Plant Roots
          Fruit
          Plant Extracts Adverse Effects
          Drug Combinations
          Toxicity Tests
          Mutagenicity Tests
          Drug Toxicity
          Animal Studies
          In Vitro Studies
          In Vivo Studies
          Rats
          Plant Extracts Administration and Dosage
          Descriptive Statistics
          Data Analysis Software
          Parametric Statistics
          Analysis of Variance
          Post Hoc Analysis
          Kruskal-Wallis Test
          Mann-Whitney U Test
          T-Tests
          Funding Source
          Mutagens
          Bone Marrow
          Erythrocytes Analysis
          Chromosome Aberrations
          Mutation
      ab: LN20188 is a botanical combination composed of extracts derived from Withania somnifera (L.) Dunal root and Abelmoschus esculentus (L.) Moench fruit. Our earlier investigations revealed the benefits of LN20188 in promoting gut motility and reducing constipation. The current investigation presents the toxicological profile of LN20188 following OECD guidelines for chemical testing. In an acute oral toxicity (AOT) study involving Sprague Dawley rats, no significant signs of toxicity or morbidity were observed, and the lethal dose (LD50) was determined to be greater than 2000 mg/kg body weight (b.w). Gross pathological findings further confirmed the safety of LN20188. In a repeated‐dose subchronic toxicological investigation, rats were administered either 500, 1000, or 1500 mg/kg b.w of LN20188 for 90 consecutive days. LN20188 was found to be safe, where data on body weight, food consumption, organ weights, hematology, clinical biochemistry, and biomarkers were comparable to those of vehicle controls. The estimated no‐observed‐adverse‐effect level (NOAEL) for LN20188 in male and female rats is determined to be 1500 mg/kg b.w. Genotoxicity studies, including bacterial reverse mutation, in vitrochromosomal aberration (CA), and in vivo micronucleus test (MNT) in mouse bone marrow erythrocytes, indicated no clastogenic or mutagenic activity. Results of the bacterial reverse mutation assay showed that LN20188 did not exhibit a notable increase in colony count (mutagenicity) up to 5000 μg/plate. In CA assay, LN20188 concentrations of up to 1000 μg/mL in the short term and 500 μg/mL in continuous exposure did not induce any chromosomal aberrations. Additionally, in vivo MNT showed that LN20188, up to 2000 mg/kg b.w, did not elevate the frequency of micronucleated PCEs (MNPCEs). Overall, these studies demonstrate that oral administration of LN20188 does not result in toxicity or genotoxic effects.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N